Irina Timofte
Rank 83 by 10-year citations to CLAD papers (23 papers, 394 citations). Role unknown; field: respiratory medicine.
As of . Primary source: OpenAlex author profile.
Summary
Irina Timofte. Role: unknown. No source read in this review states the role of this author. Field indicated by the unit name: respiratory medicine, critical care (source: affiliation lines on the author's own papers, for example https://doi.org/10.1016/j.eclinm.2026.104180 (2026): "Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA"; also on https://doi.org/10.1016/j.jhlto.2026.100524, https://doi.org/10.1111/ctr.70415, ). Affiliation: unknown (marked missing). Basis: unverified; OpenAlex lists "The University of Texas Southwestern Medical Center" on the most recent corpus paper (2026). Not confirmed as current.. Counts in the OpenAlex corpus (retrieved 2026-10-10): 23 papers and 394 citations over ten years; 0 first-author and 2 last-author papers. Ranks: main 83, excluding consensus papers 68, first or last author 449. The method is stated once on the People list page. Linked papers are the most-cited corpus papers of this author.
Citation ranks (10 years)
| Main rank | Rank excluding consensus papers | Rank by first or last author papers |
|---|---|---|
| 83 of 800 | 68 of 794 | 449 of 512 |
Citations: 394 in total, 394 excluding consensus and guideline papers (0 of this author's papers excluded), 0 on first or last author papers (0 first, 2 last).
Ranking method: see the methodology note at the top of the People list and the full methodology document.
Role and field
- Role
- unknown
- Role status
- unknown (no source read in this review states the role)
- Field
- respiratory medicine, critical care
- Field basis
- affiliation lines on the author's own papers, for example https://doi.org/10.1016/j.eclinm.2026.104180 (2026): "Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA"; also on https://doi.org/10.1016/j.jhlto.2026.100524, https://doi.org/10.1111/ctr.70415,
Only what a cited source supports is stated. Entries marked self-asserted come from the person's own ORCID record. The field is taken from the name of the unit, not inferred from the person's name.
Details
- papers 10y
- 23
- fractional papers 10y
- 1.47
- citations 10y
- 394
- fractional citations 10y
- 22.8
- ranking retrieved
- 2026-10-10
- openalex author id
- A5109502942
- merged open alex profiles
- 2
- affiliation basis
- unverified; OpenAlex lists "The University of Texas Southwestern Medical Center" on the most recent corpus paper (2026). Not confirmed as current.
- papers excluding consensus 10y
- 23
- citations excluding consensus 10y
- 394
- consensus papers excluded 10y
- 0
- first author papers 10y
- 0
- last author papers 10y
- 2
- lead author citations 10y
- 0
- lead author papers 10y
- 2
Sources and links
- OpenAlex author profile (primary)
- Most-cited CLAD paper in corpus: Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD) (The Journal of Heart and Lung Transplantation, 2021); 55 citations; DOI 10.1016/j.healun.2021.02.008
- Most-cited CLAD paper in corpus: A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation (ERJ Open Research, 2019); 35 citations; DOI 10.1183/23120541.00167-2019
- Most-cited CLAD paper in corpus: Transcripts associated with chronic lung allograft dysfunction in transbronchial biopsies of lung transplants (American Journal of Transplantation, 2022); 32 citations; DOI 10.1111/ajt.16895
- Most-cited CLAD paper in corpus: The molecular features of chronic lung allograft dysfunction in lung transplant airway mucosa (The Journal of Heart and Lung Transplantation, 2022); 18 citations; DOI 10.1016/j.healun.2022.08.014
- Most-cited CLAD paper in corpus: Anti‐Thymocyte Globulin as a Therapy for Chronic Lung Allograft Dysfunction: A Single‐Center Experience (Clinical Transplantation, 2024); 2 citations; DOI 10.1111/ctr.15461
- Own paper naming the unit (affiliation line)
- Own paper naming the unit (affiliation line)
Related
Links from this record
Known gaps in this record
- role or job title
- centre membership relation (not asserted)
- funding and conflicts of interest
- verified current affiliation
- ORCID
- only the top-30 entries were checked by hand for ID merges and splits
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.